Summary of Product Characteristics
last updated on the eMC:
30/07/2008
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 30/07/2008 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 4.8 - Undesirable Effects
-
Change to section 5.2 - Pharmacokinetic Properties
-
Change to section 10 date of revision of the text
-
Change to section 1 -Name of the Medicinal product
-
Change to section 4.2 - Posology and method of administration
|
| Date of revision of text on the SPC: 01-Mar-2008 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Sections 1, 4.2, 4.4, 4.8, 5.1 and 5.2 : change in the name of the product from “Minims Proxymethacaine” to “Minims Proxymethacaine Hydrochloride”
Section 10: update of revision date: 03/2008
|
|
Updated on 15/09/2003 and displayed until 30/07/2008
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 31/07/2001 and displayed until 15/09/2003
|
Reasons for adding or updating:
|
|
|
|
Updated on 15/03/2000 and displayed until 31/07/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 15/03/2000
|
Reasons for adding or updating:
|
|
|
|
